IBX vs PHX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

44LOW

PHX

PHARMX FPO [PHX]

44LOW

Score Breakdown

IBX PHX
Technical
61
67
Catalyst
50
61
Sentiment
50
50
Fundamental
11
74
Momentum
62
76
Risk Gate
37
50

Key Metrics

IBX Metric PHX
$10.3MMarket Cap$72.5M
2.0MAvg Volume (20d)682K
N/AShort InterestN/A
$0.05552-Week High$0.200
$0.01152-Week Low$0.066
+22.2%Daily Change+4.8%
$0.022Entry Price$0.110
N/AROE-5.9%
N/AProfit Margin-12.2%

Active Signals

IBX Signals

MACD just crossed bullish — momentum is shifting to the upside
Above-average volume (1.8x) on a green day — buyers stepping up
Watch out — volume is flowing out even as price holds up. Distribution pattern
On a tear — up 15.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.8 quarters)
4C filed 2026-01-28
Very high P/S ratio (141.1x)

PHX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Stochastic just turned bullish from a low level — early reversal sign
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Moderate P/S ratio (9.5x)
Small-cap ($20-100M)

Ask Scout AI to compare IBX and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IBX Full Analysis → PHX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).